Clinical Trials Directory

Trials / Completed

CompletedNCT02071381

Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

A Randomized, Open Label, Single-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between DW330SR and DW1030 in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
—
Sponsor
Daewon Pharmaceutical Co., Ltd. · Industry
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
—

Summary

The purpose of this study is to evaluate drugs interactions to compare pharmacokinetics in groups of monotherapy DW330SR, monotherapy DW1030, and coadministration DW330SR and DW1030

Conditions

Interventions

TypeNameDescription
DRUGDW330SR 45mg
DRUGDW1030 75mg

Timeline

Start date
2014-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2014-02-25
Last updated
2015-03-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02071381. Inclusion in this directory is not an endorsement.